NCT00346827View on ClinicalTrials.gov

"Apomorphine Nasal Powder in the Treatment of Parkinson's Disease Off Periods."

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Parkinson's Disease
Interventions
DRUG

Apomorphine Nasal Powder

Sponsors
All Listed Sponsors
lead

Britannia Pharmaceuticals Ltd.

INDUSTRY